对于COVID-19感染的儿科患者体外生命支持利用的结果
Jillian C Jacobson1, Mark L Ryan1, Adam M Vogel2
1From the Division of Pediatric Surgery, Children's Medical Center & Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
儿童COVID-19患者在体外生命支持 (ECLS) 上的结果显示,54.4%的生存率. 年龄较大,替代疗法和较长的ECLS启动时间与这些重症儿童的死亡率较高有关.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 传染性疾病 传染性疾病
- 支持心肺血管的支持.
背景情况:
- 对于COVID-19需要体外生命支持 (ECLS) 的儿科患者的结果没有得到充分的记录.
- COVID-19对儿童构成重大风险,有时需要先进的呼吸和循环支持.
研究的目的:
- 评估接受COVID-19 ECLS治疗的儿科患者的结果.
- 为了确定与这群人群的住院死亡率相关的预后因素.
主要方法:
- 一项多机构的回顾性观察研究包括来自美国14个中心的79名儿科患者.
- 数据是从2020年1月至2022年7月期间治疗的患者的电子病历中提取的.
- 静脉 (VV) ECLS是超过一半的患者使用的主要方式.
主要成果:
- 在医院出院后的生存率为54.4%.
- 不幸存者年龄较大,更有可能需要置换疗法,从入院到ECLS启动的间隔较长,并且经历了较高的ECLS相关并发症率.
- 在16.3%的幸存者中观察到神经缺陷.
结论:
- 患有COVID-19且需要ECLS的儿科患者表现出显著的发病率.
- 老年,需要置换疗法,延迟ECLS启动和ECLS并发症等因素与死亡率增加有关.
- 需要进行进一步的研究,以优化对这一脆弱群体的管理策略.
更多相关视频
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
相关概念视频
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
